PBEvsRAYS
Invesco Dynamic Biotechnology & Genome ETF against Global X Solar ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| PBE | RAYS | |
|---|---|---|
| Expense ratio | 0.58% | 0.50% |
| Assets | $424M | $7286.40T |
| Net flow, 1 month | −$50M | — |
| Net flow, 1 year | +$114M | — |
| Return, YTD | +15.8% | — |
| Return, 1 year | +32.8% | — |
| Avg daily volume | 18K | — |
| Holdings | 31 | 49 |
| Listed | Jun 23, 2005 | Sep 8, 2021 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS